Torrent said on Sunday that it would acquire a controlling stake in JB Pharma from global investment firm KKR, at an equity value of ₹25,689 crore. The deal will be followed by a merger of the two entities. The deal may be completed in 15-18 months, and is likely to be funded through debt.
